Deals
Consortium funds Eucodis with EUR 2m
Existing investors Pontis Capital, Wiener Wachstumsfonds, IBG und Arax have invested EUR 2m in enzyme company Eucodis Bioscience.
HTGF and Bayern Kapital invest in InnoMotix
High-Tech Gründerfonds and Bayern Kapital have invested in pneumatics company InnoMotix GmbH.
Scope invests EUR 7m into Footbalance
Swedish growth investor Scope has backed the Finnish producer of moulded insoles Footbalance.
BC and AXA's Medica set to become latest listing
French care home business Medicaтs flotation could be a sign that the IPO market is in rude health.
Amplio invests in solar project
Dedicated environmental investors The Amplio Group has completed and connected two plants of 1MW each expecting to connect four additional 1MW plants by the end of the month.
Advent latest to hunt on Warsaw Exchange
Advent's EUR 100m buyout of WsiP marks the second take-private in two months from one of Europe's busiest stock markets. But why are investors choosing Warsaw? Kimberly Romaine reports
Argos Soditic reaps more than 4.5x on Dinno Santé exit
Argos Soditic, FHH Conseil and the management have sold their 100% stake in Dinno Santé to the healthcare business of Air Liquide and in doing so have realised over 4.5x return.
Doughty-backed Avanza acquires two new concessions
Doughty Hanson transport business, Grupo Avanza has made two acquisitions previously managed by Grupo Trapsa.
Buyouts 2009: The year of lost opportunities
Despite plenty of "dry powder," 2009 ranks as one of the worst years in private equity history. Eckhoff and Eftimiu present unquote"s European Buyout Review
Frog Capital invests EUR 3m in agri.capital
Growth capital investor Frog Capital has invested EUR 3m in biogas producer agri.capital.
Charterhouse favourite for £500m United Utilities sale
Charterhouse Capital Partners is understood to have gained the edge on a ТЃ500m bid for utility company United Utilities Contract Solutions (UUCS).
Secondaries players to fill later-stage gap
A lack of LP appetite has left a void at the later-stage end of the European venture market. Could secondaries players hold the key, asks Emanuel Eftimiu
Survitec deal bodes strong year for buyouts
This week's foursome of sizable buyouts have put Europe on course to reach EUR 40bn for 2010, 50% larger than 2009's dire figure, writes Kimberly Romaine.
Growth to remain strong in 2010
While the Belgian buyout market has suffered along with the rest of Europe over the last two years, growth capital has gone from strength to strength. Francinia Protti-Alvarez reports.
LSP in €21.7m series B round for Merus
Life Sciences Partners (LSP), Novartis Option Fund, Pfizer and Bay City Capital have co-led a €21.7m series B financing round for biopharmaceutical Merus.
PPM Oost sells its stake in biotech incubator
PPM Oost and Wageningen University and Research Center have sold their stakes in the biotech incubator BioPartner Wageningen Center to developer and investor Kadans Vastgoed.
SBOs: To Xafinity and beyond
Duke Streetтs sale of employee benefits company Xafinity to Advent International marks the second major secondary buyout in as many days. With the buyout market currently a dichotomy between cash-rich and exit-starved managers, SBOs could be set to rocket....